Xiaolong Liang

Title: Innovations of Xiaolong Liang in Biomedical Materials

Introduction

Xiaolong Liang is a prominent inventor based in Beijing, China. He has made significant contributions to the fields of nanomaterials and biomedical materials. His innovative work focuses on developing advanced technologies that enhance medical diagnostics and treatment.

Latest Patents

Xiaolong Liang holds a patent for a fluorescent contrast agent with a targeting function. This patent, titled "Fluorescent contrast agent with targeting function, and preparation method and use thereof," describes a novel fluorescent contrast agent known as MR780 NPs. This agent specifically binds to CD206 on the surface of tumor-associated macrophages (TAMs). The MR780 NPs accumulate in lymph nodes invaded by tumor cells and undergo an oxidation-reduction reaction with reduced glutathione in a tumor microenvironment. This reaction triggers a fluorescence signal, allowing for the diagnosis of lymph node metastasis (LNM) of breast cancer. The agent aids in preoperative evaluation, assists in clinical tumor staging, and facilitates accurate surgical resection under intraoperative fluorescence navigation.

Career Highlights

Xiaolong Liang has worked at prestigious institutions, including Peking University and Ordos Clinical Medical College of Inner Mongolia Medical University. His research and innovations have garnered attention in the medical community, particularly for their potential impact on cancer diagnostics and treatment.

Collaborations

Xiaolong Liang has collaborated with notable colleagues, including Shumin Wang and Duo Zhao. Their combined expertise has contributed to advancements in the field of biomedical materials.

Conclusion

Xiaolong Liang's innovative work in developing a targeted fluorescent contrast agent represents a significant advancement in cancer diagnostics. His contributions to nanomaterials and biomedical materials continue to influence the medical field positively.